Montana's selling experimental drugs legally now. what it actually changes for you (and what it doesnt)

This ones doing the rounds today so figured its worth breaking down properly, cause the headline is doing a LOT of work here.

What actually passed - Montana's SB 535, signed last year. Lets licensed clinics sell treatments that have only completed Phase I trials, skipping the normal FDA approval route. Patients dont need to be terminally ill. Companies pay a $12,500 application fee and can set whatever price they want. Clinics supposed to be open by end of this year and applications are moving now, which is why its back in the news.

Now heres the part nobody's mentioning. Any drug sold this way has to be manufactured inside Montana. Thats not some weird quirk, its the entire reason the law works - federal law still requires FDA approval for anything crossing state lines, so the only way around it is keeping the whole chain in state.

Which means practically - this is a licensed clinic pathway with in-state manufacturing. Its not a loosening of anything on the consumer side. Nobody's buying reta off a website more legally today than they were last week. if your sourcing gray market your situation is exactly the same as it was.

What it does tell you is direction. access is slowly getting formalised in places and the clinic side is professionalising a bit. probably good long term.

But heres the thing we'd actually watch, and its why this is worth a post instead of just a shrug.

Laws like this create a legitimacy halo. and legitimacy halos get borrowed. Expect to start seeing "experimental treatment" and "Phase I cleared" and "legal under Montana law" turning up on sites that have absolutely nothing to do with a licensed Montana clinic. Real sounding credential, nothing behind it - which is structurally the exact same trick as a COA from a lab that doesnt exist.

So same rule as always. legal somewhere isnt the same as verified. a shop borrowing regulatory language isnt operating under that regulation, and none of it tells you whats actually in the vial. that question still has one answer and its an independent test you can actually confirm.

if anyone spots shops starting to use Montana framing in their marketing, drop it here. genuinely curious how fast it shows up

· 2 replies

2 replies

Questions and observations. No sourcing, no codes, no links out.

@mossywindow Research assistant ◆ FIRST REPLYa month ago

The part I keep coming back to is the difference between a state-created access route and a general change in drug status. This may let a licensed Montana center and a treating provider offer a qualifying experimental treatment, but it does not make the treatment FDA-approved, prove that it works, or turn ordinary online RUO sales into the same thing. The practical test will probably be what happens after the headline: which treatments are actually offered, what they cost, how outcomes and adverse events are recorded, and whether unclear or negative results remain visible.

@Peptigrity Junior researcher◆ FIRST RESPONDER X5a month ago

Good point on Phase I - worth stressing it's a safety read in a few dozen people, not an efficacy signal. "Phase I cleared" means it didn't obviously harm a small group over a short window. Plenty of things clear that and fail Phase III on the thing you actually cared about.

Your outcome-reporting question is the one that matters though. Whoever sells the treatment ends up deciding which results get recorded. Same structural problem as shop-provided COAs - nobody's faking anything, the party with a reason to prefer certain results just controls which ones you see.

Don't know what SB 535 actually requires there. If anyone finds the licensing conditions, post them - whether adverse events have to be reported anywhere public probably decides if this is a real access route or just an unregulated one with paperwork.